Sarepta治疗 SRPT 深 沪
已收盘 12-12 16:00:00 美东时间
21.53
-0.220
-1.01%
华盛通- 最 高21.74
- 今 开21.72
- 成交量 200.88万股
- 最 低 21.18
- 昨 收 21.75
- 总市值 21.04亿
- 52周最高 129.84
- 市盈率 静 9.21
- 换手率 2.06%
- 52周最低 10.415
- 委 比 19.13%
- 总股本 9771.34万
- 历史最高 181.83
- 量 比 0.61
- 振 幅 2.57%
- 历史最低 0.433
- 每 手 1
- 风险率 39.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sarepta Therapeutics Refinances Convertible Senior Notes
Sarepta Therapeutics ( ($SRPT) ) has issued an announcement. On December 10, 20...
12-11 20:27
美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
12-10 10:33
Sarepta a new outperform at Wedbush as selloff overdone
Wedbush has initiated Sarepta Therapeutics (SRPT) at outperform saying that a selloff that began earlier this year following the deaths of two boys who were taking one of its Duchenne muscular dystrop...
12-10 00:03
Wedbush Initiates Coverage On Sarepta Therapeutics with Outperform Rating, Announces Price Target of $32
Wedbush analyst Yun Zhong initiates coverage on Sarepta Therapeutics (NASDAQ:SRPT) with a Outperform rating and announces Price Target of $32.
12-09 21:15
Dyne's Duchenne Drug Shows Strong Muscle And Function Improvements
Dyne Therapeutics reported positive results from Phase 1/2 DELIVER trial for z-rostudirsen in DMD amenable to exon 51 skipping.
12-09 02:37
Sarepta Grants CEO Equity Awards After Eight Years
An announcement from Sarepta Therapeutics ( ($SRPT) ) is now available. On Dece...
12-08 20:58
Solid Biosciences: Better Positioned To Compete In DMD Gene Therapy, Says Bullish Analyst
Analyst Gil Blum initiated coverage of Solid Biosciences with a Buy rating and $16 price target, citing emerging gene therapies.
12-05 04:38
What's Going On With Arrowhead Shares Wednesday?
Arrowhead shares are trading higher Wednesday after the company reported better-than-expected fourth quarter financial results.
11-27 04:59
Tech Stocks Surge Ahead Of Thanksgiving, Robinhood Rallies 10%: What's Moving Markets Wednesday?
Stocks were mainly higher at midday as Wall Street traded higher ahead of the Thanksgiving holiday. Investors are likely optimistic as markets enter what is typically the strongest stretch of the year for corporate sales.
11-27 02:31
Sarepta Secures FDA Nod For Elevidys Study To Reduce Liver Injury Risk
FDA approves dosing in Sarepta's ENDEAVOR Cohort 8 to test sirolimus with Elevidys in non-ambulant Duchenne patients, targeting reduced liver injury.
11-26 01:07
